BioSpace News Archive

Today Orexo announced the publication of a manuscript, " A Personalized, Interactive, Cognitive-Behavioral Therapy-Based Digital Therapeutic

Newron Pharmaceuticals S.p.A., a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, announces that it has received Tranche 5 under its financing agreement with the European Investment Bank that was signed in October 2018 and comprises up to EUR 40 million, subject to achieving a set of agreed performance criteria.

Phase Genomics leverages its proprietary ultra-long-range sequencing technology in release of new RUO platform: the first high-resolution, low-cost solution to detect chromosome abnormalities

Lysogene announces today that it will give an oral presentation at the ESGCT 2021 Annual Virtual Conference on its gene therapy drug candidate LYS-GM101 in GM1 gangliosidosis.

AB SCIENCE GRANTED AUTHORIZATION FROM THE FRENCH HEALTH AUTHORITY (ANSM) TO INITIATE A STUDY OF AB8939 IN THE TREATMENT OF ACUTE MYELOID LEUKEMIA (AML)

Pharnext SA today announces the publication of the data from the Company’s first phase III placebo-controlled clinical study of PXT3003 in Charcot-Marie-Tooth disease Type 1A (‘CMT1A’)

Abivax SA today reports new results from an extended set of patients in its ongoing open-label maintenance study, following the phase 2b induction study of once-daily oral 50mg ABX464 to treat ulcerative colitis (UC).

United BioPharma, Shanghai Public Health Clinical Centre and NCKU to explore the effectiveness of UB-621 to clinical isolates in mainland China and Taiwan

Vomaris Innovations, Inc. announces the first patient enrollment in a study using its bioelectric antimicrobial wound care technology following surgical treatment for Hidradenitis Suppurativa (HS).

Encodia , a privately held biotech company developing next-generation solutions for proteomics research, announced the hiring of Nigel Beard, Ph.D., as Chief Technology Officer (CTO).